WilliamCameronMcManigleMD

Critical Care Medicine

Physician

Dr. McManigle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

2 citations
Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.
Sonali J Bracken, Amy N Suthers, Rachel A DiCioccio, Hsuan Su, Sarah Anand
Blood Advances. 2024-02-13
1 citations
Development and Assessment of Simulation-Based Point-of-Care Ultrasound Curriculum in Undergraduate Medical Education.
Nancy L Hagood, Monica Klaybor, Romik Srivastava, William McManigle, John Terrill Huggins
Journal of Medical Education and Curricular Development. 2023-11-09
8 citations
A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.
Chenyu Lin, Rachel A DiCioccio, Tarek Haykal, William C McManigle, Zhiguo Li
Transplantation and Cellular Therapy. 2023-03-01

Abstracts/Posters

Single-Cell RNA-Seq Identifies Potentially Pathogenic B Cell Populations That Uniquely Circulate in Patients with Chronic Gvhd
William C. McManigle, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host Disease
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019